Krystal Biotech, Inc. to Post Q3 2024 Earnings of $0.41 Per Share, William Blair Forecasts (NASDAQ:KRYS)

Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Investment analysts at William Blair lifted their Q3 2024 earnings estimates for Krystal Biotech in a research report issued to clients and investors on Tuesday, February 27th. William Blair analyst T. Lugo now expects that the company will post earnings per share of $0.41 for the quarter, […]

Leave a Reply

Your email address will not be published.

Previous post Q3 2024 Earnings Estimate for Krystal Biotech, Inc. (NASDAQ:KRYS) Issued By William Blair
Next post Royal Bank of Canada Lowers ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target to $35.00